1Ruggierol-Lopez D, Lecomte M, Moinet G, et al. Reaction of metformin with dicarbonyl compounds possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol, 1999, 58(11): 1765-1773
2Scheen AJ. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs, 1997, 54(3): 355-368
3Airey M, Benett C, Nicolucci A, et al. Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev, 2000, 2: CD002182
4Banditelli S, Boldrini E, Vilardo PG, et al. A new approach against sugar cataract through aldose reductase inhibitors. Exp Eye Res, 1999, 69(5):533-538
5Komers R, Vrana A. Thiazolidinediones-tools for the research of metabolic syndrome X. Physiol Res, 1998, 47(4):215-225
6Kosegawa I, Chen S, Awata T, et al. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in otsuka Long Evans Tokushima fatty rats. Clin Exp hypertens, 1999, 21(3): 199-211
7Kawamori R, Morishima T, Kubota M, et al. Influence of oral sulfonyurea agents on hepatic glucose uptake. Diabetes Res Clin Pract, 1995, 28(Suppl): S109-S113
8Fonseca V, Rosenstock J, Patwardhan R, et al. Effect of metformin and roseglitazone therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. JAMA, 2000, 283(13): 1695-1702
9Large V, Beylot M. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effect of metformin. Diabetes, 1999, 48(6): 1251-1257
10Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J, 2000, 348(pt3): 607-614
